The Convergence of Digital Health and Life Sciences

Despite the challenges of interoperability, regulatory compliance, technology adoption, and data privacy, the benefits of digital health are undeniable. Collaboration between policymakers, clinicians, IT developers, and patients, can help overcome these obstacles. The post The Convergence of Digital Health and Life Sciences appeared first on MedCity News.

Read More

Limitados por políticas de Trump, los registros de cáncer solo reconocerán a pacientes como “hombre” o “mujer”

Las máximas autoridades en estadísticas del cáncer de Estados Unidos pronto deberán clasificar el sexo de los pacientes estrictamente como hombre, mujer o desconocido, un cambio que, según científicos y defensores de pacientes, afectará negativamente la salud de la población transgénero, una de las más marginadas del país. Médicos y activistas por los derechos de…

Read More

Induced Mesenchymal Stem Cells: A New Frontier in Ovarian Cancer Treatment

Ovarian cancer urgently needs bold, transformative treatment approaches – not just small, incremental improvements. Synthetic, allogeneic iMSCs as tumor-targeting delivery vehicles are an example of how cell biology and engineering may unite and overcome longstanding oncology challenges. The post Induced Mesenchymal Stem Cells: A New Frontier in Ovarian Cancer Treatment appeared first on MedCity News.

Read More